Safety, pharmacodynamics, and activity of rituximab in patients with relapsing-remitting multiple sclerosis: a phase I, multicentre, open-label clinical trial

被引：0

作者：

Bar-Or, A.

Calabresi, P.

Arnold, D. L.

Markowitz, C.

Shafer, S.

Kasper, L.

Waubant, E.

Gazda, S.

Fox, R.

Panzara, M.

Sarkar, N.

Agarwal, S.

Smith, C.

机构：

[1] McGill Univ, Montreal, PQ H3A 2T5, Canada

[2] Johns Hopkins Univ, Baltimore, MD 21218 USA

[3] Hosp Univ Philadelphia, Philadelphia, PA USA

[4] Vero Neurology, Vero Beach, FL USA

[5] Dartmouth Med Sch, Lebanon, NH USA

[6] Univ Calif San Francisco, San Francisco, CA 94143 USA

[7] Texas Neurosci Inst, San Antonio, TX USA

[8] Cleveland Clin, Cleveland, OH 44106 USA

[9] Genentech Inc, San Francisco, CA USA

来源：

MULTIPLE SCLEROSIS | 2007年 / 13卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S165 / S166

页数：2